首页>British Journal of Clinical Pharmacology>Population pharmacokinetics of serelaxin in patients with acute or chronic heart failure, hepatic or renal impairment, or portal hypertension and in healthy subjects
Population pharmacokinetics of serelaxin in patients with acute or chronic heart failure, hepatic or renal impairment, or portal hypertension and in healthy subjects
作者单位:AbbVie Clinical Pharmacology and PharmacometricsAbbVie Inc.Chicago,IL,USA[1]Disease Modeling – Clinical Pharmacology, Roche Pharma Research and Early DevelopmentF. Hoffmann‐La[2]Translational MedicineNovartis Pharma A.G.Basel,Switzerland[3]PharmacometricsNovartis Institutes for BioMedical ResearchCambridge,MA,USA[4]